is semaglutide being banned Compound versions of GLP-1 drugs for weight loss halted by FDA Drug compounders sue FDA over

47 SGLT2-I approved in the US for the treatment of T2DM include canagliflozin (Invokana, 2013), dapagliflozin (Farxiga, 2014), and empagliflozin (Jardiance, 2014)

,

From August to September of 2025, 486 new plaintiffs joined the group lawsuit against GLP-1 drug manufacturers, bringing the total to 2,676

Room-temperature storage accelerates molecular degradation, which can occur within days rather than weeks

And while it isnt discussed as frequently, it is a recognised experience for some people during GLP-1 treatment especially in the early phases or after dose adjustments

So maybe theyre getting a higher dose, Jay said